SUTRO BIOPHARMA, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 134 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-10-01: Reporting owner Skyline Venture Partners V LP | KANEKO YASUNORI | Skyline Venture Management V, LLC; Form 4; Security Series C Preferred Stock; Transaction C Conversion of derivative security.
- 2018-10-01: Reporting owner Skyline Venture Partners V LP | KANEKO YASUNORI | Skyline Venture Management V, LLC; Form 4; Security Series D Preferred Stock; Transaction C Conversion of derivative security.
- 2018-10-01: Reporting owner Skyline Venture Partners V LP | KANEKO YASUNORI | Skyline Venture Management V, LLC; Form 4; Security Series E Preferred Stock; Transaction C Conversion of derivative security.
- 2018-10-01: Reporting owner CELGENE CORP /DE/; Form 4; Security Series C-2 Redeemable Convertible Preferred Stock; Transaction C Conversion of derivative security.
STRO insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-10-01 | Skyline Venture Partners V LP | KANEKO YASUNORI | Skyline Venture Management V, LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Skyline Venture Partners V, L.P. | C Conversion of derivative security | −25,015,635 0 owned after | $0.00 | $146.50 | 2018-10-03 |
| 2018-10-01 | Skyline Venture Partners V LP | KANEKO YASUNORI | Skyline Venture Management V, LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By Skyline Venture Partners V, L.P. | C Conversion of derivative security | −12,846,023 0 owned after | $0.00 | $146.50 | 2018-10-03 |
| 2018-10-01 | Skyline Venture Partners V LP | KANEKO YASUNORI | Skyline Venture Management V, LLC 10% Owner | 10% Owner | 10% Owner | 4 | Series E Preferred Stock Derivative · Indirect · By Skyline Venture Partners V, L.P. | C Conversion of derivative security | −18,698,578 0 owned after | $0.00 | $146.50 | 2018-10-03 |
| 2018-10-01 | CELGENE CORP /DE/ 10% Owner | 4 | Series C-2 Redeemable Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −8,338,892 0 owned after | $0.00 | $146.50 | 2018-10-02 |
| 2018-10-01 | CELGENE CORP /DE/ 10% Owner | 4 | Series D Redeemable Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,845,114 0 owned after | $0.00 | $146.50 | 2018-10-02 |
| 2018-10-01 | CELGENE CORP /DE/ 10% Owner | 4 | Series D-2 Redeemable Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −18,097,331 0 owned after | $0.00 | $146.50 | 2018-10-02 |
| 2018-10-01 | CELGENE CORP /DE/ 10% Owner | 4 | Series E Redeemable Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −18,726,075 0 owned after | $0.00 | $146.50 | 2018-10-02 |
| 2018-10-01 | Merck & Co., Inc. | Merck Sharp & Dohme Corp. 10% Owner | 10% Owner | 4 | Series E Redeemable Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −74,794,315 0 owned after | $0.00 | $146.50 | 2018-10-02 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | C Conversion of derivative security | −21,776 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | C Conversion of derivative security | −131,683 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | C Conversion of derivative security | −64,815 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | C Conversion of derivative security | −1,835,270 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | C Conversion of derivative security | −11,097,596 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | C Conversion of derivative security | −5,462,550 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | C Conversion of derivative security | −17,533 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | C Conversion of derivative security | −106,019 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | C Conversion of derivative security | −52,183 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | C Conversion of derivative security | −9,217,015 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | C Conversion of derivative security | −6,683,697 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series E Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | C Conversion of derivative security | −9,155,794 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | C Conversion of derivative security | −194,786 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | C Conversion of derivative security | −141,249 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series E Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | C Conversion of derivative security | −193,492 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | C Conversion of derivative security | −21,776 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | C Conversion of derivative security | −131,683 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | C Conversion of derivative security | −64,815 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | C Conversion of derivative security | −1,835,270 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | C Conversion of derivative security | −11,097,596 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | C Conversion of derivative security | −5,462,550 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | C Conversion of derivative security | −17,533 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | C Conversion of derivative security | −106,019 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | C Conversion of derivative security | −52,183 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | C Conversion of derivative security | −9,217,015 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | C Conversion of derivative security | −6,683,697 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series E Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | C Conversion of derivative security | −9,155,794 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | C Conversion of derivative security | −194,786 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | C Conversion of derivative security | −141,249 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Ross Michael Jay Director, 10% Owner | 4 | Series E Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | C Conversion of derivative security | −193,492 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | NEWELL WILLIAM J Director, Officer (CEO & President) | 4 | Series C Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −55,657 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | NEWELL WILLIAM J Director, Officer (CEO & President) | 4 | Series D Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −192,267 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | NEWELL WILLIAM J Director, Officer (CEO & President) | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −50,000 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | JANNEY DANIEL Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Indirect · By Alta Partners VIII, L.P. | C Conversion of derivative security | −10,201,769 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | JANNEY DANIEL Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Alta Partners VIII, L.P. | C Conversion of derivative security | −12,387,324 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | JANNEY DANIEL Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By Alta Partners VIII, L.P. | C Conversion of derivative security | −9,449,318 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | JANNEY DANIEL Director, 10% Owner | 4 | Series E Preferred Stock Derivative · Indirect · By Alta Partners VIII, L.P. | C Conversion of derivative security | −18,698,578 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Hallam Trevor Officer (Chief Science Officer) | 4 | Series D Preferred Stock Derivative · Direct | C Conversion of derivative security | −50,033 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Freund John Gordon Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By Skyline Venture Partners V, L.P. | C Conversion of derivative security | −25,015,635 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Freund John Gordon Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Indirect · By Skyline Venture Partners V, L.P. | C Conversion of derivative security | −12,846,023 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Freund John Gordon Director, 10% Owner | 4 | Series E Preferred Stock Derivative · Indirect · By Skyline Venture Partners V, L.P. | C Conversion of derivative security | −18,698,578 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | FITZPATRICK LINDA A Officer (Chief People & Comm. Officer) | 4 | Series B Preferred Stock Derivative · Indirect · By Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997 | C Conversion of derivative security | −85,015 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | FITZPATRICK LINDA A Officer (Chief People & Comm. Officer) | 4 | Series C Preferred Stock Derivative · Indirect · By Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997 | C Conversion of derivative security | −94,633 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | FITZPATRICK LINDA A Officer (Chief People & Comm. Officer) | 4 | Series D Preferred Stock Derivative · Indirect · By Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997 | C Conversion of derivative security | −48,595 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Alta Partners VIII, L.P. | CHAMPSI FARAH | NOHRA GUY P | Alta Partners Management VIII, LLC | JANNEY DANIEL 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −10,201,769 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Alta Partners VIII, L.P. | CHAMPSI FARAH | NOHRA GUY P | Alta Partners Management VIII, LLC | JANNEY DANIEL 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Direct | C Conversion of derivative security | −12,387,324 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Alta Partners VIII, L.P. | CHAMPSI FARAH | NOHRA GUY P | Alta Partners Management VIII, LLC | JANNEY DANIEL 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 4 | Series D Preferred Stock Derivative · Direct | C Conversion of derivative security | −9,449,318 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | Alta Partners VIII, L.P. | CHAMPSI FARAH | NOHRA GUY P | Alta Partners Management VIII, LLC | JANNEY DANIEL 10% Owner | 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 4 | Series E Preferred Stock Derivative · Direct | C Conversion of derivative security | −18,698,578 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-10-01 | ALBINI EDWARD C Officer (CFO and Secretary) | 4 | Series D Preferred Stock Derivative · Direct | C Conversion of derivative security | −41,694 0 owned after | $0.00 | $146.50 | 2018-10-01 |
| 2018-09-27 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,183 5,361 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +6,183 64,815 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III (LPI) L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −521,159 451,869 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LPI) L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +521,159 5,462,550 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III Strategic Partners L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,978 4,315 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V (GP), LP | ILSF III, LLC | SV Life Sciences Fund V Strategic Partners, L.P. | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +4,978 52,183 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,183 5,361 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +6,183 64,815 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III (LPI) L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −521,159 451,869 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LPI) L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +521,159 5,462,550 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III Strategic Partners L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,978 4,315 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-27 | Ross Michael Jay Director, 10% Owner | 4 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners L.P. | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +4,978 52,183 owned after | $0.48 exercise price | $152.00 | 2018-10-01 |
| 2018-09-26 holding as of filing | CELGENE CORP /DE/ 10% Owner | 3 | Series C-2 Redeemable Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | CELGENE CORP /DE/ 10% Owner | 3 | Series D Redeemable Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | CELGENE CORP /DE/ 10% Owner | 3 | Series D-2 Redeemable Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | CELGENE CORP /DE/ 10% Owner | 3 | Series E Redeemable Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | Holding | $0.48 exercise price | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | Holding | $0.48 exercise price | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | Holding | $0.48 exercise price | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series E Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series D Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | Ross Michael Jay Director, 10% Owner | 3 | Series E Preferred Stock Derivative · Indirect · By SV Life Sciences Fund V Strategic Partners, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III Co-Investment, L.P. | Holding | $0.48 exercise price | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | Holding | no price filed | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series C Preferred Stock Warrant (right to buy) Derivative · Indirect · By International Life Sciences Fund III (LP1), L.P. | Holding | $0.48 exercise price | 2018-09-26 | ||
| 2018-09-26 holding as of filing | ILSF III, LLC | SVLSF V, LLC | INTERNATIONAL LIFE SCIENCES FUND III STRATEGIC PARTNERS, L.P. | INTERNATIONAL LIFE SCIENCES FUND III CO-INVESTMENT, L.P. | SV Life Sciences Fund V Strategic Partners, L.P. | SV LIFE SCIENCES FUND V LP | INTERNATIONAL LIFE SCIENCES FUND III (LP1), L.P. | SV Life Sciences Fund V (GP), LP | INTERNATIONAL LIFE SCIENCES FUND III (GP), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · By International Life Sciences Fund III Strategic Partners, L.P. | Holding | no price filed | 2018-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |